Since the NS3 protease domain was shown to be imported into mitochondria more efficiently than the full-length protein (18), we used NS3pro and the catalytically inactive mutant in our first set of experiments, whose results were then confirmed using the full-length protein or in the context of infection. The gene discussed is KRAS; the disease is infection.